Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cresco Labs (CRLBF) Other Non Operating Income (2019 - 2025)

Historic Other Non Operating Income for Cresco Labs (CRLBF) over the last 7 years, with Q3 2025 value amounting to -$13.4 million.

  • Cresco Labs' Other Non Operating Income fell 26714000.0% to -$13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.2 million, marking a year-over-year increase of 7134.53%. This contributed to the annual value of -$61.9 million for FY2024, which is 365913.79% down from last year.
  • Latest data reveals that Cresco Labs reported Other Non Operating Income of -$13.4 million as of Q3 2025, which was down 26714000.0% from -$836000.0 recorded in Q2 2025.
  • Over the past 5 years, Cresco Labs' Other Non Operating Income peaked at $14.8 million during Q3 2022, and registered a low of -$59.5 million during Q2 2024.
  • For the 5-year period, Cresco Labs' Other Non Operating Income averaged around -$2.1 million, with its median value being $317000.0 (2025).
  • In the last 5 years, Cresco Labs' Other Non Operating Income skyrocketed by 1753150.68% in 2021 and then plummeted by 26714000.0% in 2025.
  • Over the past 5 years, Cresco Labs' Other Non Operating Income (Quarter) stood at $10.9 million in 2021, then crashed by 76.89% to $2.5 million in 2022, then tumbled by 101.98% to -$50000.0 in 2023, then tumbled by 6444.0% to -$3.3 million in 2024, then plummeted by 308.37% to -$13.4 million in 2025.
  • Its Other Non Operating Income stands at -$13.4 million for Q3 2025, versus -$836000.0 for Q2 2025 and $317000.0 for Q1 2025.